In both plants and animals, innate immunity is triggered through pattern recognition receptors (PRRs) in response to microbe-associated molecular patterns (MAMPs)[@R6],[@R7] to provide the first line of inducible defense. Plant receptor kinases represent the main functions of known plasma membrane PRRs for MAMP recognition to distinguish nonself from self[@R6]. FLS2 is the first characterized plant leucine rich repeat (LRR) receptor kinase that perceives the bacterial flagellin and launches convergent downstream signalling and defense pathways for potentially broad-spectrum pathogen resistance[@R5],[@R6],[@R9]--[@R11]. The perception of bacterial flagellin is conserved in seed plants and functional FLS2 orthologs are found from *A. thaliana* to rice[@R5],[@R6]. As *FLS2* is expressed throughout the whole plant including the SAM ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"})[@R5],[@R12], flagellin-FLS2 signalling could provide immune protection in different parts of the plant body after infections.

While developing a plant expression system to screen for peptide-mediated receptor-like kinase (RLK) signalling, we observed that the endogenously modified 12-amino acid CLV3p ([Supplementary Table 1](#SD1){ref-type="supplementary-material"})[@R13] triggered similar responses as flg22 (the conserved 22-amino acid peptide of bacterial flagellin) in mesophyll protoplasts[@R5],[@R6],[@R9],[@R14]--[@R16]. This finding was unexpected because CLV3p is normally expressed, secreted and processed by the stem cells to control SAM maintenance via CLV1 and CLV2 receptors[@R1],[@R2],[@R4],[@R13],[@R17]. Flg22 and CLV3p, but not ΔCLV3p lacking the last His residue, activated similar MAPK activities detected by the in-gel kinase assay ([Fig. 1a](#F1){ref-type="fig"} and [Supplementary Fig. 3](#SD1){ref-type="supplementary-material"})[@R6],[@R9],[@R14]--[@R16]. Highly purified CLV3p synthesized by different sources displayed the same activities, ruling out the contamination possibility. We sought to identify the CLV3p receptor in leaf cells by examining MAPK activation in various receptor mutants. Neither the dominant *clv1-1* mutant ([Fig. 1a](#F1){ref-type="fig"}) nor the *clv2-1* mutant ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"})[@R1],[@R2],[@R4],[@R17]--[@R19] affected CLV3p-triggered MAPK activation. Surprisingly, two independent L*er* and Col-0 *fls2* mutant alleles[@R5],[@R6], but not *efr-1* (the bacterial elongation factor EF-Tu receptor EFR) mutant[@R20], failed to support the activation of MAPKs by both flg22 and CLV3p ([Fig. 1a](#F1){ref-type="fig"} and [Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). Complementation with the WT *FLS2* gene ([Fig. 1b](#F1){ref-type="fig"}) but not *CLV1* (data not shown) in the *fls2* mutant confirmed that FLS2 could recognize both flg22 and CLV3p to mediate MAPK signalling. Importantly, CLV3p and flg22 activated similar early marker genes, including *FRK1*, *WRKY29* and *WRKY30* ([Fig. 1c](#F1){ref-type="fig"})[@R9],[@R10],[@R14].

FLS2 signalling requires the recruitment of RLK BAK1 and the interaction between FLS2 and BAK1 represents the earliest event (within a minute) triggered by flg22 binding to FLS2[@R6],[@R14]--[@R16]. Like flg22, CLV3p also induced the immediate interaction between FLS2 and BAK1 detected by reciprocal co-immunoprecipitation (co-IP) ([Supplementary Fig. 5a, b](#SD1){ref-type="supplementary-material"})[@R14]--[@R16]. Consistently, CLV3p signalling monitored by MAPK activation was greatly diminished in the *bak1-4* mutant ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"})[@R14]--[@R16]. Significantly, CLV3p pretreatment could confer enhanced resistance to the pathogenic bacteria *Pseudomonas syringae pv. tomato* (*Pst*) DC3000 in an FLS2 dependent manner ([Fig. 1d](#F1){ref-type="fig"})[@R10],[@R14]. These comprehensive analyses strongly support our new finding that the conserved flagellin receptor FLS2 can recognize the stem cell peptide CLV3p and trigger the convergent innate immune signalling[@R6],[@R9],[@R14].

Peptide titration experiments using the FLS2 and BAK1 co-IP assay showed that 1 nM flg22 was as potent as 1 μM CLV3p ([Fig. 2a](#F2){ref-type="fig"} and [Supplementary Fig. 5c](#SD1){ref-type="supplementary-material"}) required for SAM suppression[@R13],[@R21]. Intriguingly, flg22 and CLV3p peptides supported similar primary gene activation but distinct long-term growth effects in seedling assays ([Figs 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"} and [Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). Flg22 is a MAMP from non-self invaders and detected by a very sensitive perception system[@R22] to induce innate immunity in a timely manner after infection. CLV3p, on the other hand, is an endogenous plant signal naturally secreted in the stem cell zone to activate constitutive innate immunity via FLS2 in the SAM, which might provide a type of "vaccination" before any infections to elicit sufficient immune protection without severe growth penalty caused by MAMPs ([Fig. 3a--e](#F3){ref-type="fig"})[@R5],[@R6],[@R15],[@R20].

*CLV3* belongs to the *CLV3/ERS*-related (*CLE*) gene family, which is conserved in diverse plant species[@R4],[@R17]--[@R19]. The *Arabidopsis* genome has 32 *CLE* genes[@R4],[@R17]--[@R19]. CLV3p and many other CLE peptides share similar root growth inhibition activity through the CLV2-CRN (CORYNE)/SOL2 (SUPPRESSOR OF OVEREXPRESSION OF LLP1-2) receptor complex, revealing a high degree of redundancy in peptide signalling[@R18],[@R19]. To assess the specificity of CLV3p-FLS2 signalling, we examined the activity of synthetic peptide CLE40p, which belongs to the same CLE subgroup as CLV3p[@R4],[@R17],[@R18],[@R21]. CLE40p triggered the growth arrest of SAM, repression of *WUSCHEL* (*WUS*) detected by *pWUS::GUS*[@R23], and root growth inhibition ([Supplementary Fig. 8a, b](#SD1){ref-type="supplementary-material"}) as previously reported for CLV3p and CLE19p[@R4],[@R17],[@R18],[@R21]. *WUS* encodes a homeo-domain transcription factor playing a central role in *Arabidopsis* SAM maintenance [@R1],[@R2]. However, CLE40p did not promote FLS2-BAK1 interaction or flg22 early marker gene activation ([Fig. 2a](#F2){ref-type="fig"} and [Supplementary Fig. 8c](#SD1){ref-type="supplementary-material"}). CLV3p-FLS2 signalling might be unique among CLE peptides.

To determine whether flg22 and CLV3p triggered FLS2 signalling through the same or different extracellular sites, we carried out competition experiments using a well-established antagonist peptide lacking only the last 2 amino acids at the C-terminus of flg22 (flg22-Δ2)[@R24]. Based on the CLV3p- or flg22-triggered FLS2-BAK1 interaction assay by co-IP, we showed that flg22-Δ2 effectively competed with and blocked flg22 and CLV3p signalling ([Fig. 2b](#F2){ref-type="fig"}). Moreover, two LRR mutants, one in the 10^th^ LRR domain (*fls2-24*) and the other in the 23^rd^ LRR domain (the *LRR23b* mutant) of FLS2, failed to activate flg22 and CLV3p signalling detected by MAPK activation despite normal FLS2 protein levels ([Fig. 2c](#F2){ref-type="fig"})[@R9],[@R14]--[@R16],[@R24]--[@R26]. These results suggest that flg22 and CLV3p likely share binding and activation sites in the extracellular LRR domain of FLS2.

Based on the established studies on the flg22-FLS2 and CLV3p-CLV1 interactions[@R27],[@R28], we developed a cell-based assay to show that ^125^I-Tyr-CLV3p interacted directly with FLS2 expressed in the null *fls2* mutant protoplasts. Importantly, only the wild-type FLS2 protein but not the fls2-24 and LRR23b mutant protein or the brassinosteroid receptor kinase (BRI1) showed specific binding to ^125^I-Tyr-CLV3p ([Fig. 2d](#F2){ref-type="fig"}). The saturation binding curve and Scatchard plot were generated using the specific binding assay. The estimated dissociation constant (Kd) for FLS2 and ^125^I-Tyr-CLV3p interaction was 34.7 nM ([Fig. 2e](#F2){ref-type="fig"}), which was close to the Kd for CLV1 and CLV3p interaction[@R28]. The specific binding could be competed by the unlabeled Tyr-CLV3p, CLV3p, flg22, flg22-Δ2, but not CLE40 ([Fig. 2f](#F2){ref-type="fig"} and [Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). Tyr-CLV3p and CLV3p displayed identical effectiveness in competing with ^125^I-Tyr-CLV3p for binding to FLS2 ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}), immune marker gene activation and root inhibition (data not shown). ^125^I-Tyr-CLV3p binding to FLS2 shared characteristic of CLV3p binding to CLV1[@R28]. Although the estimated Kd for ^125^I-Tyr-flg22 binding to FLS2 is lower[@R27] and FLS2 responses to flg22 are more sensitive ([Figs 1c, d](#F1){ref-type="fig"} and [2a](#F2){ref-type="fig"} and [Supplementary Fig. 5a, c](#SD1){ref-type="supplementary-material"}), flg22 did not compete more effectively than Tyr-CLV3p and CLV3p for ^125^I-Tyr-CLV3p binding to FLS2. Because the sequences of CLV3p and flg22 do not share any overt similarity and ΔCLV3p was ineffective in activating or blocking FLS2 signalling ([Fig. 1a](#F1){ref-type="fig"}, data not shown), it was surprising to discover that they could still compete for some potentially shared binding sites on the LRR of FLS2 ([Fig. 2b, c, f](#F2){ref-type="fig"}). The precise location of flg22 and CLV3p binding to FLS2 awaits future co-crystallographic analysis or mass spectrometry studies on cross-linked ligand-receptor complexes.

In previous studies, innate immune responses and growth inhibition are always tightly linked[@R5],[@R6],[@R15],[@R20]. We investigated the effects of flg22 and CLV3p on seedling growth [@R5],[@R6],[@R15],[@R20]. Surprisingly, CLV3p did not inhibit shoot growth but caused stronger root growth arrest in Col-0 and L*er* WT seedlings ([Fig. 3a, c](#F3){ref-type="fig"} and [Supplementary Figs 7a and 8b](#SD1){ref-type="supplementary-material"}). While seedling growth inhibition in both shoots and roots by flg22 was eliminated in two independent *fls2* mutants, the stronger root growth arrest by CLV3p was retained ([Fig. 3b, d](#F3){ref-type="fig"}). Although CLV3p activated, via FLS2, a spectrum of innate immune responses similar to those via flg22-FLS2 signalling in mesophyll cells, seedlings and the SAM ([Figs 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"} and [4](#F4){ref-type="fig"} and [Supplementary Figs 3, 5 and 8](#SD1){ref-type="supplementary-material"}), CLV3p did not stimulate the typical flg22-FLS2-mediated growth suppression in whole seedlings ([Fig. 3a--e](#F3){ref-type="fig"}). Similar to other synthetic CLE peptides, CLV3p triggered root growth arrest was abolished in the *clv2-1* mutant ([Fig. 3c--e](#F3){ref-type="fig"} and [Supplementary Fig. 7](#SD1){ref-type="supplementary-material"})[@R18],[@R19]. Thus, CLV3p-FLS2 signalling activated only immune responses but not the general growth inhibition. Significantly, CLV3p was very active in triggering the typical SAM arrest in null *fls2* seedlings ([Fig. 3f--i](#F3){ref-type="fig"})[@R1],[@R2],[@R4],[@R13],[@R17]--[@R19],[@R23],[@R28]. The SAM growth arrest was correlated with the repression of a sensitive *pWUS::GUS* reporter in the organizing centre by the exogenous CLV3p but not ΔCLV3p or flg22 ([Fig. 3j--m](#F3){ref-type="fig"})[@R23].

Because CLV3p is specifically expressed and secreted from stem cells of the SAM[@R1],[@R2],[@R4],[@R13],[@R17],[@R23], it is critical to examine CLV3p-FLS2 signalling in the SAM to evaluate its physiological relevance. Using qRT-PCR analysis with isolated SAM tissues, CLV3p clearly triggered two parallel signalling pathways in the SAM ([Fig. 4a, b](#F4){ref-type="fig"} and [Supplementary Figs 10--13](#SD1){ref-type="supplementary-material"}). The activation of important immune marker genes by CLV3p in WT, *clv1-1*, *clv2-1* but not *fls2-24* validated the action of innate immune signalling via FLS2 in the *Arabidopsis* SAM. These flg22 and CLV3p inducible genes, including *FRK1 (a RLK)*, *WRKY29, WRKY30, MYB15, MYB51* (transcription factors) and *PEP3* (a peptide inhibiting *Pst* DC3000 growth via RLK signalling), play important roles in bacterial and fungal resistance[@R6],[@R9],[@R10],[@R14]. Consistently, some of these marker genes showed reduced endogenous expression in the SAM of *clv3-2*, but were constitutively expressed at higher levels in the SAM but not other tissues of WT ([Supplementary Figs 10, 11a and 12](#SD1){ref-type="supplementary-material"}). Their endogenous expression levels were low in both the SAM and other tissues in *clv3-2* and *fls2-24* ([Supplementary Fig. 12](#SD1){ref-type="supplementary-material"}). Complementation of *clv3-2* for immune marker gene expression in the SAM could be achieved with nM range of exogenous CLV3p, reflecting the physiological relevance of the Kd for CLV3p and FLS2 interaction and CLV3p-FLS2 signalling in the SAM ([Fig. 2e](#F2){ref-type="fig"} and [Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}). The flg22 induction of these immune marker genes was observed in the SAM of *clv1-1*, *clv2-1* and *clv3-2* mutants, supporting the potency of MAMP signalling via FLS2 ([Fig. 4a](#F4){ref-type="fig"} and [Supplementary Fig. 11b](#SD1){ref-type="supplementary-material"}). At 10--100 pM flg22, the immune marker gene induction levels were reduced in the SAM of *clv3-2* compared to those in the SAM of WT and *clv1-1*, suggesting the operation of both CLV3p-FLS2 and flg22-FLS2 signalling pathways in the SAM ([Supplementary Fig. 13](#SD1){ref-type="supplementary-material"}). The repression of *WUS* was triggered by CLV3p only in the SAM of WT and *fls2-24,* but not *clv1-1* and *clv2-1* ([Fig. 4b](#F4){ref-type="fig"})[@R1],[@R2],[@R4],[@R17],[@R19],[@R23].

Most strikingly, we have never detected the presence of a single live *Pst* DC3000-GFP bacterium in the SAM of WT seedlings in 11 infection experiments by visualizing bacteria proliferation using confocal microscopy for up to 4 days ([Fig. 4c](#F4){ref-type="fig"} and [Supplementary Fig. 14a](#SD1){ref-type="supplementary-material"}). Because *Pst* DC3000-GFP could be easily visualized in the infected WT and *clv3-2* cotyledons ([Supplementary Fig. 14b, d](#SD1){ref-type="supplementary-material"}), the WT SAM appeared to exhibit differential immunity ([Fig. 4c](#F4){ref-type="fig"} and [Supplementary Fig. 14a](#SD1){ref-type="supplementary-material"}). Significantly, the SAM was no longer protected from *Pst* DC3000-GFP infection in *fls2-24* and *clv3-2* mutants ([Fig. 4c](#F4){ref-type="fig"} and [Supplementary Fig. 14c, e, f](#SD1){ref-type="supplementary-material"}), supporting the important role of the endogenous CLV3p in the SAM protection through the FLS2-mediated innate immune signalling pathway ([Fig. 4c](#F4){ref-type="fig"} and [Supplementary Figs 1 and 14](#SD1){ref-type="supplementary-material"}). To further demonstrate and quantify the proliferation and growth of *Pst* DC3000-GFP in the SAM of the *fls2-24* and *clv3-2* mutants observed after 2 to 4 days of infection, we counted the increasing bacteria numbers and carried out quantitative PCR analysis of the GFP DNA from the bacteria, both indicating the loss of the distinct SAM immunity ([Fig. 4c](#F4){ref-type="fig"} and [Supplementary Figs 14e and 15](#SD1){ref-type="supplementary-material"}). There were higher numbers of *Pst* DC3000-GFP bacteria in the bigger *clv3-2* SAM with more cells of similar size but not bigger cells ([Supplementary Fig. 14c, e](#SD1){ref-type="supplementary-material"}). Importantly, *Pst* DC3000-GFP was found to be completely excluded from the similarly enlarged *clv1-1* and *clv2-1* SAM, in which the CLV3p-FLS2 signalling remained active ([Fig. 4c](#F4){ref-type="fig"}). Based on qPCR analysis of GFP DNA derived only from *Pst* DC3000-GFP, non-specific bacteria attachment background could be estimated from the SAM tissue samples 1 h after bacteria-seedling co-cultivation. Consistent with confocal microscopic observations, active bacteria growth and proliferation were exclusively detected only in the SAM of the *clv3-2* and *fls2-24* mutants ([Supplementary Fig. 15](#SD1){ref-type="supplementary-material"}).

We have uncovered a surprising mechanism underlying the stem cell-triggered immunity for pathogenic bacteria protection through CLV3p-FLS2 signalling ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). It will be interesting to examine the SAM protection from a variety of other pathogens. We propose that CLV3p is recognized by two distinct types of receptors involved in mostly non-overlapping functions in the SAM ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). The "constitutive" immunity in the SAM resembles flg22 pretreatment as a type of vaccination (before infection), which is more effective to confer protection against virulent pathogens such as *Pst* DC3000 possessing effectors to cripple MAMP signalling[@R6],[@R14]. It is amazing that CLV3p-FLS2 signalling seems to have evolved to provide constitutive immune protection in the SAM but avoid the penalty from potent growth suppression associated MAMP signalling[@R5],[@R6],[@R15],[@R20]. A future challenge is to elucidate the precise differential downstream signalling events via the same receptor in response to different peptide ligands. Lacking the genes for antibodies and immune cell receptors in humans[@R29] to respond to new signals from diverse invaders, plant RLKs, displaying high polymorphism and fast evolution[@R30], may provide an alternative means to recognize self or nonself in a beneficial manner through constant selections in evolution. It will also be important to explore the roles of other secreted plant peptides and known or orphan receptors in innate immunity[@R4],[@R6],[@R17],[@R30].

METHODS SUMMARY {#S1}
===============

Plasmid constructs {#S2}
------------------

The constructs for expressing FLS2-HA and BAK1-FLAG for co-IP were reported previously[@R14]. LRR23b-HA and fls2-24-HA are mutant variants of the LRR domain of FLS2, which were generated by site-directed mutagenesis. The *fls2-24* allele is a Gly to Arg mutation in the 10^th^ LRR domain of FLS2 and insensitive to flg22[@R25]. The LRR23b is mutated in two amino acids (Gln to Leu and Phe to Leu) in the 23^rd^ LRR domain of FLS2 and lacks flg22 signalling[@R26].

Mesophyll protoplas transient assays {#S3}
------------------------------------

Protoplast isolation and transient expression assays were performed as previously described[@R9],[@R14]. For protein expression in co-IP and in-gel kinase assays, protoplasts were transfected with plasmid DNA and incubated for 6 h at room temperature. Then, peptides such as CLV3p and flg22 were added for 10 min to induce MAPK activation or FLS2-BAK1 interaction. For qRT-PCR analysis, protoplasts were treated with peptides for 1 h.

In-gel kinase assay and co-IP {#S4}
-----------------------------

Both experiments were performed according to previously described[@R9],[@R14]. MBP (Invitrogen) was used as a substrate for endogenous MPK3 and MPK6 activation analysis[@R9]. For co-IP, FLS2-HA and BAK1-FLAG were co-immunoprecipitated by an anti-FLAG antibody (Sigma) and detected by an anti-HA antibody (Roche) in immunoblot analysis.

METHODS {#S5}
=======

Plant materials and growth conditions {#S6}
-------------------------------------

Col-0 and L*er* were used as wild type *Arabidopsis* plants in this study. The *bak1-4, efr-1,* and *fls2* (*Salk_141277*) mutants are in Col-0 background[@R14],[@R15],[@R20] and *clv1-1*, *clv2-1*, *clv3-2,* and *fls2-24* are in L*er* background[@R5],[@R31],[@R32]. The *clv1-1* mutation is in the kinase domain and represents a dominant negative allele[@R33]. The mutation of *clv2-1* causes the early stop codon at the 33^rd^ residue and is a null allele[@R34]. The γ-ray-induced *clv3-2* is a presumed null allele[@R33],[@R35]. Wild type and mutant plants were grown on soil at 23°C, 65% humidity, and 75 μmol m^−2^ s^−1^ light intensity under 12 h light/12 h dark photoperiod condition for 4 weeks before mesophyll protoplast isolation[@R36]. For liquid culture of *Arabidopsis* seedlings, seeds were germinated and grew in 6-well plates containing 1 ml of liquid medium (0.5 × MS and 0.5% sucrose, pH 5.8 adjusted with KOH). For GUS assay in the SAM and qRT-PCR analysis using SAM tissues, seedlings were grown for 8 days. For growth inhibition analysis by flg22 and CLV3p, seedlings were grown at same condition for 8 days ([Fig. 3a, b](#F3){ref-type="fig"} and [Supplementary Fig. 8b](#SD1){ref-type="supplementary-material"}) or 6 days ([Fig. 3c--e](#F3){ref-type="fig"} and [Supplementary Fig. 7b](#SD1){ref-type="supplementary-material"}).

QRT-PCR analysis {#S7}
----------------

Total RNA was isolated from protoplasts or SAM tissues with TRIzol reagent (Invitrogen). To harvest SAM tissues, seedlings were instantaneously frozen by liquid nitrogen in the mortar pre-chilled on the dry ice. Cotyledons, hypocotyls and roots were removed using fine forceps. The purity of the harvested SAM tissue was confirmed by SAM specific marker genes and the absence of marker genes not expressed in the SAM ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"})[@R12]. First strand cDNA was synthesized from 1 μg of total RNA with M-MLV reverse transcriptase (Promega). All qRT-PCR analyses were performed by CFX96 real time PCR detection system with iQ SYBR green supermix (Bio-Rad). *ACT2* (*ACTIN2*, *At3g18780*) was used as a control gene.

GUS staining {#S8}
------------

GUS staining was performed as described[@R23]. Plants were fixed in 90% cold acetone for 20 min and rinsed twice in staining buffer without X-Gluc (5-Bromo-4-chloro-3-indoxyl-beta-D-glucuronide). Samples were infiltrated with staining buffer \[100 mM NaPO~4~ buffer, pH 7.0; 0.5 mM Ferrocyanide; 0.5 mM Ferricyanide; 0.1% Triton X-100; 10 mM EDTA, pH 8.0; 1 mM X-Gluc (Gold Biotechnology, Inc)\] under vacuum for 10 min and incubated at 37°C for 3 h. After then, staining buffer was removed and dehydrated up to 70% ethanol. Microscopic analysis was carried out with Leica DFC 500 camera mounted on Leica MZ16F.

Bacterial infection assay in the SAM {#S9}
------------------------------------

Nine seeds were sowed in 1 ml liquid medium in 6-well plates and grown under constant light (50--65 μmol m^−2^ s^−1^) at 25--27°C without shaking. *Pst* DC3000-GFP culture was grown in KB liquid medium (50 μg/ml of rifampicin and 15 μg/ml of Tetracyclin) with shaking at 28°C. Overnight cultured *Pst* DC3000-GFP were washed twice with water and diluted to OD~600~=0.02. Diluted *Pst* DC3000-GFP (50 μl) was added into the liquid medium with 2 day-old seedlings. Plants and bacteria were co-cultivated with gentle shaking (50 rpm) for 2, 3 or 4 days under constant light. For observation of bacteria infected SAM, co-cultivated seedlings were washed with 70% ethanol twice and rinsed twice with water. All seedlings were placed on glasse slides with 1 ml of water, and squashed gently by cover slips for bacterial observation using a confocal laser-scanning microscope (Leica TCS-NT). The experiment was repeated at least five times with similar results in L*er*, *fls2-24*, *clv3-2*, *clv1-1* and *clv2-1* ([Fig. 4c](#F4){ref-type="fig"}). For the qPCR analysis of DC3000-GFP, diluted *Pst* Dc3000-GFP (OD~600~ = 0.5, 200 μl) was co-cultivated with WT or mutant seedlings for 3 or 4 days. After washing and rinsing seedlings twice, tissues from five SAMs were harvested and ground in 100 μl of water. Control experiments were conducted at 0 DAC (day after co-cultivation) to determine non-specific bacterial attachment 1 h after co-cultivation (black bar). The experiment was repeated three times with similar results. The GFP level determined by qPCR was correlated with specific bacterial growth, and normalized based on the *Arabidopsis ACT2* gene in the SAM tissues.

Seedling pathogen assay {#S10}
-----------------------

The protocol was modified from previously described[@R37],[@R38]. Nine seeds were sowed in 6-well plates containing 1 ml of liquid medium. Plants were grown under constant light at 25--27°C without shaking. *Pst* DC3000 culture were grown in KB liquid medium (50 μg/ml of rifampicin) with shaking at 28°C. Overnight cultured *Pst* DC3000 was washed twice with water and diluted to OD~600~=0.02, 1 × 10^7^ cfu/ml. After 6 days of seedling growth, 50 μl of diluted *Pst* DC3000 was added into 1 ml of fresh 0.5 × MS liquid medium without sucrose. After adding *Pst* DC3000, plates containing plants and bacteria were co-cultivated with gentle shaking (\<50 rpm) for 1 day under constant light (50--65 μmol m^−2^ s^−1^). For CLV3p- and flg22-induced immunity, seedlings were treated with 1 μM or 10 μM of CLV3p or 100 nM of flg22 peptide 1 day before adding *Pst* DC3000. For bacterial counting, co-cultivated seedlings were washed with 70% ethanol twice and rinsed twice with water. Then, three seedlings were put into each of three 1.5 ml tubes containing 100 μl of water and ground by a hand drill and blue pestles. After preparing serial dilutions, 10 μl of diluted bacteria (from 10^−3^ to 10^−5^) was spread on the KB plates and incubated for 2 days at 28°C before counting.

Assay for CLV3p-mediated SAM arrest {#S11}
-----------------------------------

Twenty seeds of Col-0 and *fls2* mutant were sowed in petri dishes (100 × 25 mm) containing 10 ml of liquid medium with or without 1 μM CLV3p. Plants were grown in a growth chamber at 23°C under short day condition (8 h light:16 h dark, 75 μmol m^−2^ s^−1^) for 4 weeks. The SAM tissues were cut and fixed using 4% (w/v) paraformaldehyde/4% (v/v) DMSO at 4°C for overnight. Collected samples were dehydrated through ethanol series (30%, 50%, 70%, 95% for 1 h in each step) at 4°C and stained with 0.1% Eosin Y (Sigma) in 100% ethanol at 4°C for overnight. Ethanol was changed through histoclear series (50% ethanol: 50% histoclear, 100% histoclear, 100% histoclear for 1 h in each step) (National Diagnostics). Histoclear was then gradually changed with melted paraffin (Fisher Scientific) in a 60°C chamber. Replacement of freshly melted paraffin was performed for 4 days. Paraffin embedded tissues were poured into the mold and adjusted in appropriated position. Section was carried out with a rotary microtome (Leica RM2255) at 8 μm thickness. Sectioned ribbons were placed on poly-prep glass slides (Sigma) with pre-warm water and incubated on slide warmer (Fisher Scientific) at 42°C for overnight. For meristem staining, paraffin of sections was removed by 100% histoclear twice for 10 min. Sectioned tissues were hydrated through reverse ethanol series (100%, 70%, 30% ethanol and water for 2 min in each step). Sections were stained with 0.1% Giemsa (Sigma) for 5 min and rinsed briefly with water. Stained sections were dehydrated through ethanol series (2 min in each step) and transferred to 100% histoclear for 2 min. For microscopic analysis, samples were dried and mounted with Cytoseal 60 (Richard-Allan Scientific) before taking pictures using Leica DM5000B.

Direct Binding Assay {#S12}
--------------------

The protocol was modified from previously described[@R39]--[@R41]. For reparation of receptor proteins, FLS2-HA, fls2-24-HA, LRR23b-HA and BRI1-HA were expressed in *fls2* protoplasts (2.5 × 10^5^ cells) for 6 h. Protoplasts were harvested and then resuspended in 500 μl of binding buffer (25 mM MES/KOH, pH 5.8, 3 mM MgCl~2~, 10 mM NaCl) with 2 mM DTT and protease inhibitor (Roche). Cells were vigorously mixed by vortex and kept on ice for 5 min, and centrifuged at 10,000 ×g for 20 min to yield pellet. The pellets were resuspended in 100 μl of binding buffer and the protein concentration from resuspended extract was measured by a NanoDrop 1000 spectrophotometer. This extract contained 50 μg of total protein. For the binding assay, resuspended extracts (100 μl) in binding buffer were mixed with ^125^I-Tyr-CLV3p (100 fmol in each sample) without or with unlabeled Tyr-CLV3p as a competitor for 30 min on ice. The average of specific radioactivity in five different batches of ^125^I-Tyr-CLV3p was 2,023.52 Ci/mmole. ^125^I-Tyr-CLV3p bound extracts were collected by a vacuum filtration system through glass fiber filters (Macherey-Nagel MN GF-2, 2.5-cm diameter), which were pre-incubated with 1% BSA, 1% bactotrypton, 1% bactopepton in binding buffer. Filters were washed with 15 ml of cold binding buffer and the retained radioactivity was determined by a gamma counter Beckman LS6500. Specific binding was measured by subtracting non-specific binding (with 10--20 μM unlabeled Tyr-CLV3p competitor) from total binding (without competitor). In the saturation binding assay, the non-specific binding in the presence of 20 μM unlabeled Tyr-CLV3p competitor showed linear increase with 1 to 100 nM ^125^I-Tyr-CLV3p and accounted for 40 \~ 60 % of total binding, which was similar to the range of non-specific binding observed with ^125^I-Tyr-flg22 binding to intact cells ([Fig. 3A](#F3){ref-type="fig"}, Bauer et al., 2001). The dissociation constant (*K~d~*), Scatchard plot and the non-linear regression analysis of competition assay were presented using the Prism 5 program (GraphPad). From the saturation data of Bmax = 0.53 pmol/mg protein and 50 ug protein from 2.5 × 10^5^ cells, 6.36 × 10^4\ 125^I-Tyr-CLV3p binding sites per cell could be estimated in total cell extracts. Specific CLV3p binding to FLS2 was similar to CLV3p binding to CLV1 and CLV2, the established CLV3p receptors[@R40]--[@R42].
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![CLV3p and flg22 activate similar downstream responses through FLS2\
**a**, MAPK activity analysis. L*er*, *clv1-1* and *fls2-24* protoplasts were treated with 1 μM CLV3p (C), 1 μM ΔCLV3p (ΔC) or 100 nM flg22 (F) for 10 min. **b**, FLS2-HA complements *fls2*. **c**, CLV3p triggers flg22 marker gene activation. Quantification by qRT-PCR. Peptides treatment for 1 h. Error bars, s.d. (*n*=3). **d**, CLV3p enhances resistance to *Pst* DC3000. Error bars, s.d. (*n*=3).](nihms274380f1){#F1}

![CLV3p and flg22 share similar perception through FLS2\
**a,** CLE40p fails to induce FLS2-BAK1 interaction. Treatments: flg22 (1, 10 nM), 1 μM CLV3p or 1 μM CLE40p for 10 min. **b**, Flg22-Δ2 blocks CLV3p and flg22 signalling. Flg22-Δ2 (50 μM). **c**, LRR mutations of FLS2 eliminate flg22 and CLV3p perceptions in *fls2*. Top, in-gel-kinase assay. Bottom, protein expression. **d**, ^125^I-Tyr-CLV3p specifically binds to FLS2. Non-specific binding (20 μM unlabeled Tyr-CLV3p). Error bars, s.d. (*n*=3). **e,** Saturation binding curve and Scatchard plot. Error bars, s.d. (*n*=3). **f,** Binding competition analysis with peptides. Error bars, s.d. (*n*=3). Non-specific binding (10 μM unlabeled Tyr-CLV3p).](nihms274380f2){#F2}

![CLV3p-mediated SAM arrest and immune signalling are uncoupled from flg22-triggered growth suppression\
**a-e,** Growth inhibition analysis. Treatment with flg22 (1, 10 nM) or CLV3p (1 μM) in Col-0 (**a**) and *fls2* (**b**), L*er* (**c**), *fls2-24* (**d**) and *clv2-1* (**e**) seedlings. Scale bars, 1 cm. **f--i,** CLV3p suppresses the SAM in Col-0 and *fls2* plants. Red asterisks, SAM region. Scale bars, 50 μm (**f--i**). **j--m,** CLV3p represses *pWUS::GUS* expression. Treatment was without (**j**) or with 1 μM CLV3p (**k**), 1 μM ΔCLV3p (**l**) or 1 μM flg22 (**m**). Red arrows, SAM region. Scale bars, 1 mm.](nihms274380f3){#F3}

![CLV3p-FLS2 signalling enhances innate immunity for SAM protection\
**a,** Flg22 marker gene activation by CLV3p through FLS2 in the SAM. **b,** *WUS* repression by CLV3p was mediated via CLV1 or CLV2 not FLS2. The SAM tissues were analyzed by qRT-PCR after treatment with 1 nM flg22 or 1 μM CLV3p for 1 h. Error bars, s.d. (*n*=3). **c,** Infection and proliferation of pathogenic bacteria in the SAM lacking CLV3p-FLS2 signalling. *Pst* DC3000-GFP was co-cultivated with seedlings for 2 or 4 days. *Pst* DC3000-GFP was visualized using a confocal microscope. Scale bars, 50 μm. BF, bright field.](nihms274380f4){#F4}
